Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

A mutation causes a defect in the production of exosomes, which has been shown to drive the progression of Alzheimer's ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

The method offers a scalable way to scour unculturable bacteria for new drug leads and help illuminate a previously hidden microbial world.

GEN spotlights some of the remarkable women who are breaking barriers, setting standards, and driving innovation in this space.